Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Ginkgo Bioworks Holdings

DNA
Current price
7.31 USD -1.56 USD (-17.59%)
Last closed 8.6 USD
ISIN US37611X1000
Sector Healthcare
Industry Biotechnology
Exchange NYSE
Capitalization 471 835 136 USD
Yield for 12 month -88.29 %
1Y
3Y
5Y
10Y
15Y
DNA
21.11.2021 - 28.11.2021

Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming in the United States. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. It serves pharma and biotech, agriculture, industrial and environment, food and nutrition, consumer and technology, and government and defense industries. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts. Address: 27 Drydock Avenue, Boston, MA, United States, 02210

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

8.8 USD

P/E ratio

Dividend Yield

Current Year

+251 455 000 USD

Last Year

+477 706 000 USD

Current Quarter

+56 206 000 USD

Last Quarter

+37 944 000 USD

Current Year

+142 643 000 USD

Last Year

+273 490 000 USD

Current Quarter

+25 155 000 USD

Last Quarter

+15 873 000 USD

Key Figures DNA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -633 689 024 USD
Operating Margin TTM -274.48 %
PE Ratio
Return On Assets TTM -22.3 %
PEG Ratio
Return On Equity TTM -76.83 %
Wall Street Target Price 8.8 USD
Revenue TTM 184 335 008 USD
Book Value 16.03 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -30.2 %
Dividend Yield
Gross Profit TTM 273 490 000 USD
Earnings per share -18 USD
Diluted Eps TTM -18 USD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics DNA

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History DNA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:40
Payout Ratio
Last Split Date 20.08.2024
Dividend Date

Stock Valuation DNA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 1.051
Price Sales TTM 2.5597
Enterprise Value EBITDA -1.7918
Price Book MRQ 0.5664

Financials DNA

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators DNA

For 52 weeks

5.26 USD 75.2 USD
50 Day MA 7.61 USD
Shares Short Prior Month 6 345 269
200 Day MA 24.93 USD
Short Ratio 5.6
Shares Short 7 879 004
Short Percent 25.26 %